| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director | Executive Vice President +1 more
3 companies
Todisco Joseph is a Chief Executive Officer at CorMedix Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 6 buys and 4 sells.
Estimated insider holdings value: $10.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | CRMD Cormedix Inc. | Chief Executive Officer | Sale+OE | 30,000 | $12.00 | $360,000.00 | -5.6% | -46.6% | - | |
| Sep 12, 2025 | CRMD Cormedix Inc. | Chief Executive Officer | Sale+OE | 50,000 | $13.00 | $650,000.00 | -8.9% | -9.3% | - | |
| Mar 13, 2024 | CRMD Cormedix Inc. | Chief Executive Officer | Buy | 13,561 | $3.74 | $50,718.14 | +4.0% | +29.5% | +166.2% | |
| Sep 8, 2023 | CRMD Cormedix Inc. | Chief Executive Officer | Buy | 10,000 | $3.71 | $37,100.00 | +4.8% | -3.5% | +55.7% | |
| Nov 15, 2022 | CRMD Cormedix Inc. | Chief Executive Officer | Buy | 20,000 | $3.82 | $76,400.00 | +9.0% | +16.3% | -9.8% | |
| Aug 24, 2022 | CRMD Cormedix Inc. | Chief Executive Officer | Buy | 4,700 | $3.92 | $18,424.00 | +2.2% | -0.8% | +2.5% | |
| May 16, 2022 | CRMD Cormedix Inc. | Chief Executive Officer | Buy | 10,000 | $3.38 | $33,800.00 | +4.8% | +14.4% | +23.5% | |
| Dec 2, 2021 | AMRX Amneal Pharmaceuticals, Inc. | Executive Vice President | Sell | 1,500 | $4.10 | $6,150.00 | -0.5% | -3.6% | -41.7% | |
| Mar 15, 2021 | AMRX Amneal Pharmaceuticals, Inc. | Executive Vice President | Sale+OE | 36,330 | $6.82 | $247,865.06 | -11.5% | -17.5% | -43.1% | |
| Feb 28, 2020 | AMRX Amneal Pharmaceuticals, Inc. | SVP, Specialty Commercial | Buy | 40,000 | $3.62 | $144,800.00 | +19.3% | - | - |